Inventor
Chen-Chen Kan
Inventor
Del Mare, CA, US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Qprimary
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms29%
C07KPeptides21%
C30BSingle-crystal growth21%
Y02ATechnologies for adaptation to climate change21%
C12NMicroorganisms or enzymes8%
PatentTitleYear
6,849,721'Modifications of the VEGF receptor-2 protein and methods of use'20056,794,146'Modifications of the VEGF receptor-2 protein and methods of use'20046,787,327'Methods for determining tyrosine-DNA phosphodiesterase activity'20046,784,285'Modifications of the VEGF Receptor-2 Protein and methods of use'20046,753,416'Modifications of the VEGF receptor-2 protein and methods of use'20046,670,167'Catalytic domain of the human effector cell cycle checkpoint protein kinase materials and methods for identification of inhibitors thereof'20036,316,603'Modifications of the VEGF receptor-2 protein and methods of use'2001Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2001–2005Patents assigned to AGOURON PHARMA (6)· patent assignee history
2001–2005Based in Del Mare, CA, US· patent location history
2003–2004Based in Arcadia, CA, US· patent location history
2004Patents assigned to KELK GRADUATE OF APPLIED LIFE (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AGOURON PHARMA | 6 | 2001–2005 |
| KELK GRADUATE OF APPLIED LIFE | 1 | 2004 |
Locations
| Location | Patents | Span |
|---|---|---|
| Del Mare, California, US | 5 | 2001–2005 |
| Arcadia, California, US | 2 | 2003–2004 |